This chapter describes approved and banned drugs along with their indications and date of issue, which include sofosbuvir tablet 400 mg, bedaquiline tablet 100 mg, lixisenatide prefilled solution for injection 10 μg/20 μg, dapagliflozin tablet 5 mg/ 10 mg, pasireotide solution for injection 0.6 mg/0.6 mg/0.9 mg, empagliflozin tablet 10 mg/10 mg, gadobutrol solution for injection, sofosbuvir Tablet 400 mg, ledipasvir bulk, acotiamide hydrochloride bulk and tablet 100 mg, lurasidone hydrochloride bulk and lurasidone hydrochloride tablets 40 mg/80 mg etc.